Primatope Therapeutics' Unattributed Round

Primatope Therapeutics raised a round of funding on December 03, 2013.

Primatope Therapeutics has developed an antibody therapeutics discovery & development platform which enables the rapid translation of best-in-class monoclonal antibodies form the discovery to human cl…

Articles about Primatope Therapeutics' Unattributed Round: